International legal practice Osborne Clarke has advised FA Bio, a British bio-tech company, on its £5.3 million investment from three European venture capital investment funds as well as existing shareholders and new private investors. The new investment will support the commercialisation of FA Bio's technology, the company's ongoing research work and fund the expansion of its team.
Clean Growth Fund and Pymwymic co-led the investment, with participation from Ship2B Ventures. The funding reflects increasing support from global venture capital funds for the bio-tech sector.
FA Bio (formerly FungiAlert) based at Rothamsted Research Centre, is a pioneering agricultural science company. It specialises in developing advanced microbial bioproducts such as biocontrols, biostimulants and biofertilisers, to replace chemical inputs in agriculture. Dr Angela de Manzanos Guinot and Dr Kerry O'Donnelly Weaver lead the company.
Osborne Clarke's team was led by venture and growth capital partner Rob Hayes and included associate director Robert Pook, senior associate Magnus Williams and senior paralegal Fern Tawera.
Osborne Clarke's international venture capital team is a go-to practice for companies operating in tech-enabled industries. From start-up through venture financing and the growth journey beyond, whether continuing to sale, IPO or international expansion, the team has an outstanding track record advising businesses, entrepreneurs and investors that are driving innovation. Osborne Clarke's dedicated resource centre, OC Ventures, brings together experts from across our international network to deliver a seamless service to clients throughout the ventures ecosystem - read more here.
Corporate communications and press contacts
Connect with one of our experts
